Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
2.14
Dollar change
+0.23
Percentage change
12.04
%
IndexRUT P/E- EPS (ttm)-2.56 Insider Own0.94% Shs Outstand82.54M Perf Week-4.46%
Market Cap197.92M Forward P/E- EPS next Y-2.25 Insider Trans-2.55% Shs Float81.77M Perf Month-34.76%
Income-210.57M PEG- EPS next Q-0.32 Inst Own67.87% Short Float19.45% Perf Quarter-39.03%
Sales61.76M P/S3.20 EPS this Y-30.46% Inst Trans-2.43% Short Ratio7.20 Perf Half Y-59.62%
Book/sh2.13 P/B1.01 EPS next Y14.48% ROA-50.61% Short Interest15.91M Perf Year-80.74%
Cash/sh2.87 P/C0.75 EPS next 5Y1.70% ROE-78.56% 52W Range1.89 - 11.69 Perf YTD-78.87%
Dividend Est.- P/FCF- EPS past 5Y2.88% ROI-106.50% 52W High-81.69% Beta1.87
Dividend TTM- Quick Ratio3.75 Sales past 5Y101.57% Gross Margin90.46% 52W Low13.23% ATR (14)0.19
Dividend Ex-Date- Current Ratio3.75 EPS Y/Y TTM5.48% Oper. Margin-370.03% RSI (14)35.83 Volatility8.50% 7.16%
Employees265 Debt/Eq0.22 Sales Y/Y TTM150.95% Profit Margin-340.96% Recom2.16 Target Price8.50
Option/ShortYes / Yes LT Debt/Eq0.13 EPS Q/Q-36.63% Payout- Rel Volume1.26 Prev Close1.91
Sales Surprise-98.45% EPS Surprise-0.40% Sales Q/Q-98.86% EarningsNov 04 BMO Avg Volume2.21M Price2.14
SMA20-13.25% SMA50-26.68% SMA200-56.60% Trades Volume2,775,696 Change12.04%
Date Action Analyst Rating Change Price Target Change
Nov-25-24Downgrade BofA Securities Buy → Underperform $13 → $1
Nov-06-24Upgrade Evercore ISI In-line → Outperform
Nov-04-24Downgrade Raymond James Outperform → Mkt Perform
Aug-08-24Upgrade BofA Securities Neutral → Buy $13 → $15
May-09-24Upgrade Morgan Stanley Underweight → Equal-Weight $7
Oct-24-23Upgrade Citigroup Neutral → Buy $11
Oct-18-23Upgrade JP Morgan Underweight → Neutral $8
Oct-17-23Downgrade Cantor Fitzgerald Overweight → Neutral
Sep-29-23Upgrade Stifel Hold → Buy $9 → $17
Jun-12-23Upgrade Raymond James Mkt Perform → Outperform $17
Dec-04-24 11:30AM
Nov-26-24 06:50AM
Nov-06-24 09:00AM
Nov-05-24 01:59PM
Nov-04-24 08:40AM
07:36AM Loading…
07:36AM
07:30AM
Oct-31-24 03:55AM
Oct-25-24 10:00AM
Oct-22-24 12:13PM
07:15AM
07:00AM
Oct-21-24 04:30PM
Oct-18-24 04:01PM
Oct-17-24 05:01PM
06:27AM Loading…
Oct-05-24 06:27AM
Oct-04-24 07:13PM
07:33AM
Oct-03-24 06:00PM
Sep-06-24 11:31AM
Aug-28-24 09:00AM
Aug-08-24 09:33AM
03:39AM
Aug-07-24 08:05AM
07:07AM
07:00AM
Jul-31-24 07:00AM
Jul-17-24 11:30AM
Jul-09-24 07:59AM
Jul-08-24 09:00AM
08:40PM Loading…
Jun-29-24 08:40PM
06:30PM
Jun-27-24 09:04AM
Jun-26-24 09:33PM
04:36PM
Jun-25-24 08:00AM
Jun-17-24 08:13AM
Jun-14-24 03:01AM
03:00AM
Jun-07-24 11:30AM
May-22-24 07:05PM
May-14-24 07:01PM
04:27PM
10:00AM
May-10-24 06:00AM
May-09-24 03:38PM
01:12PM
12:40PM
11:33AM
08:00AM
May-08-24 10:33PM
11:55AM
08:25AM
07:29AM
07:00AM
May-02-24 07:00AM
May-01-24 10:46AM
08:00AM
Apr-29-24 10:26AM
Apr-26-24 10:00AM
Apr-22-24 04:31PM
Mar-29-24 11:30AM
Mar-07-24 03:31AM
Mar-05-24 11:52PM
Mar-04-24 10:30AM
Mar-02-24 09:49PM
Feb-29-24 11:26AM
08:42AM
Feb-28-24 11:15PM
08:10AM
07:35AM
07:08AM
07:00AM
Feb-21-24 07:00AM
Feb-19-24 09:55AM
Feb-10-24 05:09PM
Feb-06-24 12:00PM
Jan-31-24 09:00AM
Jan-28-24 08:45AM
Jan-21-24 09:37AM
Jan-17-24 12:04PM
Jan-15-24 05:19AM
Jan-11-24 04:38PM
Jan-08-24 08:15AM
07:45AM
Jan-03-24 07:00AM
Jan-02-24 10:15AM
Dec-23-23 08:02AM
Dec-14-23 08:32AM
06:30AM
Dec-13-23 05:12PM
04:06PM
12:30PM
09:00AM
Dec-11-23 01:22PM
12:00PM
Dec-10-23 11:59AM
Dec-05-23 07:00AM
Nov-29-23 02:28PM
Nov-22-23 06:30AM
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Neill Gilmore NeilCEODec 03 '24Sale2.081,6183,361312,106Dec 05 04:40 PM
Mei BaisongEVP, CHIEF MEDICAL OFFICERDec 03 '24Sale2.085411,124133,354Dec 05 04:37 PM
Mei BaisongEVP, CHIEF MEDICAL OFFICERSep 04 '24Sale3.425181,774133,895Sep 06 04:20 PM
O'Neill Gilmore NeilCEOSep 04 '24Sale3.421,5555,325313,724Sep 06 04:18 PM
O'Neill Gilmore NeilOfficerSep 03 '24Proposed Sale3.923,00011,760Aug 29 04:19 PM
Mei BaisongOfficerSep 03 '24Proposed Sale3.921,0003,920Aug 29 04:17 PM
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICERJul 25 '24Sale5.4211,88664,37073,136Jul 26 05:02 PM
Mei BaisongEVP, CHIEF MEDICAL OFFICERJul 19 '24Sale5.216,61934,456134,413Jul 22 05:01 PM
O'Neill Gilmore NeilCEOJun 04 '24Sale5.5012,19166,997315,279Jun 06 04:17 PM
Mei BaisongEVP, CHIEF MEDICAL OFFICERJun 04 '24Sale5.505112,808141,032Jun 06 04:16 PM
Lucera ErickEVP, CHIEF FINANCIAL OFFICERMay 20 '24Sale5.6122,337125,404116,829May 22 04:30 PM
Hopfield JessicaDirectorMay 13 '24Buy5.6445,000253,86867,700May 14 04:17 PM
O'Neill Gilmore NeilCEOMar 05 '24Sale9.4277,824732,884327,470Mar 05 08:00 PM
Mei BaisongSVP, CHIEF MEDICAL OFFICERMar 04 '24Sale9.4220,327191,425141,543Mar 05 07:54 PM